StataCorp Contributes Data Science Software to COVID-19 Research Database for Academic and Medical Research

COLLEGE STATION, Texas, July 7, 2020 /PRNewswire/ — StataCorp today announced that it would be joining the coalition of leading healthcare companies that have launched the COVID-19 Research Database, a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets made available pro bono to public health and policy researchers to extract insights to help combat the COVID-19 pandemic.

Researchers accessing the large, diverse repository of real-world data will be provided access to StataCorp’s data science software Stata pro bono to facilitate their analysis in the database environment. Since launching in April, more than 1000 researchers have registered for the database from more than 350 academic institutions. The scientific steering committee, chaired by Dr. Mark Cullen, the Founding Director of the Center for Population Health Sciences and a Professor of Medicine, Biomedical Data Science, and Health Research and Policy at Stanford University, has received more than 80 study submission proposals.

Early studies coming out of the database have leveraged electronic health record data to offer a localized framework for policymakers to design more optimal ways to reopen their regions; have queried mortality data to understand excess mortality since the onset of the pandemic; and have used a combination of demographic, mortality and medical claims data to examine the disproportionate impact of the disease on minority and low income populations. Dozens of additional studies are currently underway.

“We are excited to participate in the COVID-19 Research Database coalition, which has made remarkable progress in a short period of time,” said Alan Riley, President, StataCorp. “Our data science software is highly valued by academic and medical researchers, and we hope that making it available through this effort will help to accelerate our understanding of this disease.”

“Understanding and addressing COVID-19 is the challenge of our time,” said Travis May, Chief Executive Officer of Datavant, which convened the database coalition. “We are grateful to StataCorp for participating in this coalition, and look forward to putting their data science software Stata into the hands of researchers seeking to better understand this highly infectious and destructive disease.”

ABOUT STATACORP

For over 30 years, StataCorp has been a leader in statistical and data science software. Stata provides everything for research professionals’ data science needs–data manipulation, visualization, statistics, and reproducible reporting.

www.stata.com

View original content:http://www.prnewswire.com/news-releases/statacorp-contributes-data-science-software-to-covid-19-research-database-for-academic-and-medical-research-301089161.html

SOURCE StataCorp

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

45 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

15 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

18 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

18 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

18 hours ago